When combining all iPSC-RPE lines regardless of AMD disease status, we found CFB expression was significantly lower (0.5 fold, p = 0.04) and IL-6 expression was significantly higher (5-fold, p = 0.006) in iPSC-RPE derived from donors with the high-risk genotype. The gene discussed is CFB; the disease is age-related macular degeneration.